Adamczyk A,Jesko H,Strosznajder RP H .2005 .Alzheimer's disease related peptides affected cholinergic receptor mediated poly (ADP-ribose) polymerase activity in the hippocampus. Folia, 43(3) : 139-142.
Sharma L Alam J .2019 .Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review. Curr Drug Targets., 20(3) : 316-339.
Alzheimer's Disease International .2015 .The global impact of dementia. An analysis of the prevalence, incidence, cost and trends. World Alzheimer Report, : .
Cummings N,Fox N .2017 .Defining Disease Modifying Therapy for Alzheimer's Disease. J. Prev. Alzheimers Dis, 4(2) : 109-115.
Drake C,Boutin H,Jones MS,Denes A,McColl BW,Selvarajah JR .2011 .Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain. Behav, 25(6) : 1113-1122.
Feldman H,Gauthier S,Hecker J .2001 .A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology, 57(4) : 613-620.
Guzior N,Wieckowska A,Panek D,Malawska B D .2015 .Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. Curr. Med, 22(3) : 373-404.
Maier SF,Watkins LR .1998 .Cytokines for psychologists: Implications of bidirectional immuneto-brain communication for understanding behavior, mood, and cognition. Psychol, 105(1) : 83-107.
Mitchell RA,Herrmann N,Lanctot KL .2011 .The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. CNS. Neurosci. Ther., 17(5) : 411-427.
Nakamura S,Kawamata T,Akiguchi I,Kameyama M,Nakamura N,Kimura H N .1990 .Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta. Neuropathol, 80(4) : 419-425.
O'Brien JT,Holmes C,Jones M C .2017 .Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J. Psychopharmacology, 31(2) : 147-168.
Reddy AP,Ravichandran J,Carcaci-Salli J .1866 .Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders. Biochim. Biophys. Acta. Mol. Basis. Dis, : 165506.
Birks JS,Harvey RJ. .2018 .Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst. Rev., : CD001190.
Riederer P,Danielczyk W,Grunblatt E .2004 .Monoamine oxidase-B inhibition in Alzheimer's disease. Neurotoxicology., 25(1-2) : 271-277.
Rivas-Ramírez P,Roth BL,Hanizavareh SM,Blum AE .2004 .Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl), 174(1) : 17-24.
Rothenburg LS,Herrmann N,Swardfager W,Black SE,Tennen G,Kiss A .2010 .The relationship between inflammatory markers and post stroke cognitive impairment. J. Geriatr. Psychiatry Neurol, 23(3) : 199-205.
Saura J,Luque JM,Cesura AM,Da Prada M,Chan-Palay V,Huber G .1994 .Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. , 62(1) : 15-30.
Schedin-Weiss S,Inoue M,Hromadkova L,Teranishi Y,Yamamoto NG,Wiehager B .2017 .Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Neurobiol. Aging, 9(1) : 57.
Shaw S,Bencherif M,Marrero MB M .2002 .Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J. Biol. Chem, 277(47) : 44920-44924.
Shih JC .2018 .Monoamine oxidase isoenzymes: Genes, functions and targets for behavior and cancer therapy. J. Neural. Transm. (Vienna), 125(11) : 1553-1566.
Strosznajder RP,Jesko H .2005 .Poly(ADP-ribose) polymerase-1 is a novel nuclear target for cholinergic receptor signaling in the hippocampus. J. Physiol. Pharmacol., 56(4) : 209-213.
Winblad B,Kilander L,Eriksson S L .2006 .Donepezil in patients with severe Alzheimer's disease: Doubleblind, parallel-group, placebo-controlled study. Lancet, 367(9516) : 1057-1065.